Flagship cancer fund underspent amid uncertainty over its future
The following article about the underspend by the Cancer Drugs [...]
New Cancer Drugs Fund benefiting thousands of patients and releasing £140m for the NHS
NHS England have released an update on the new Cancer [...]
European guidelines for the management of metastatic renal cell carcinoma to be updated
The European Association of Urology (EAU) guidelines are to be [...]
Lenvatinib/everolimus combination approved by NICE for use in NHS England and Wales for advanced kidney cancer
Fantastic news for people with advanced kidney cancer: the lenvatinib [...]
Majority of recently-approved cancer treatments lack survival benefits
A study published in the British Medical Journal (BMJ) states that two [...]
NICE turns down two kidney cancer drugs
NICE has issued draft guidance this week turning down two [...]
Cabozantinib recommended by NICE for second-line treatment of advanced kidney cancer
Today, the National Institute for Health and Care Excellence (NICE), [...]
Cancer Drugs Fund driving early access to promising new treatments
The National Institute for Health and Care Excellence (NICE) has [...]
Cabozantinib for advanced kidney cancer rejected for the second time by NICE
Unfortunately, the National Institute for Health and Care Excellence (NICE) [...]
NICE and NHS England plans to delay access to life-saving drugs
English charities warn that patients might have to wait three years [...]
